← 產業報告目錄
Blood-Based Biomarker Market Size, Share & Trends Analysis Report By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-06頁數 180報告編號 INSIGHTACE-28997157dd
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Blood-Based Biomarker Market worldwide was assessed at USD 7.9 Bn. Analysts project it will increase to USD 15.9 Bn by 2034, at a CAGR of 7.4% spanning 2025 to 2034.
The Blood-Based Biomarker sector involves a measurable and quantifiable characteristic in the blood that indicates a particular physiological or pathological process, or a response to a therapeutic interventi. This domain has witnessed notable transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is driven by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Blood Based Biomarker Market Snapshot
Chapter 4. Global Blood Based Biomarker Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Screening Biomarker
5.2.2. Diagnosis Biomarker
5.2.3. Others
Chapter 6. Market Segmentation 2: By Disease Estimates & Trend Analysis
6.1. By Disease & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease:
6.2.1. Cancer
6.2.2. Neurological Disorders
6.2.3. Others
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
7.2.1. Diagnostics
7.2.2. Drug Discovery
7.2.3. Personalized Medicine
Chapter 8. Blood Based Biomarker Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Blood Based Biomarker Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
8.1.2. North America Blood Based Biomarker Market revenue (US$ Million) estimates and forecasts By Disease, 2021-2034
8.1.3. North America Blood Based Biomarker Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.4. North America Blood Based Biomarker Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Blood Based Biomarker Market revenue (US$ Million) By Type, 2021-2034
8.2.2. Europe Blood Based Biomarker Market revenue (US$ Million) By Disease, 2021-2034
8.2.3. Europe Blood Based Biomarker Market revenue (US$ Million) By Application, 2021-2034
8.2.4. Europe Blood Based Biomarker Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Blood Based Biomarker Market revenue (US$ Million) By Type, 2021-2034
8.3.2. Asia Pacific Blood Based Biomarker Market revenue (US$ Million) By Disease, 2021-2034
8.3.3. Asia Pacific Blood Based Biomarker Market revenue (US$ Million) By Application, 2021-2034
8.3.4. Asia Pacific Blood Based Biomarker Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Blood Based Biomarker Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
8.4.2. Latin America Blood Based Biomarker Market revenue (US$ Million) By Disease, (US$ Million) 2021-2034
8.4.3. Latin America Blood Based Biomarker Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.4.4. Latin America Blood Based Biomarker Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Blood Based Biomarker Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Blood Based Biomarker Market revenue (US$ Million) By Disease, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Blood Based Biomarker Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Blood Based Biomarker Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Diadem srl.
9.2.2. Proteomedix
9.2.3. Cleveland Diagnostics
9.2.4. F. Hoffmann-La Roche Ltd
9.2.5. GENFIT
9.2.6. Nutech Cancer Biomarkers India Pvt Ltd.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們